"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)" Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Section for Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Hematology, Oslo University Hospital, Oslo, Norway.
Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Medical Science, Section of Hematology, Uppsala University, Uppsala, Sweden.
Department Medical Biosciences, Umeå University, Umeå, Sweden.
Department of Internal Medicine, Falun General Hospital, Falun, Sweden.
Department of Hematology, Odense University Hospital, Odense, Denmark.
Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
Clinical Genomics Facility, Uppsala, Science for Life Laboratory IGP, Rudbeck Laboratory, Uppsala University and Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
Division for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Pathology, Division of Hematopathology, Karolinska University Hospital and Institute, Solna, Stockholm, Sweden.
Section for Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Show others and affiliations
2022 (English) In: Leukemia, ISSN 0887-6924, E-ISSN 1476-5551, Vol. 36, no 5, p. 1436-1439Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages Nature Publishing Group, 2022. Vol. 36, no 5, p. 1436-1439
National Category
Cancer and Oncology
Identifiers URN: urn:nbn:se:oru:diva-97987 DOI: 10.1038/s41375-022-01537-w ISI: 000767708200001 PubMedID: 35277655 Scopus ID: 2-s2.0-85126099436 OAI: oai:DiVA.org:oru-97987 DiVA, id: diva2:1644208
Funder Swedish Cancer Society
Note Funding agencies:
Bristol-Myers Squibb Celgene Corporation
Nordic Cancer Union
2022-03-142022-03-142024-01-02 Bibliographically approved